For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Site Tools
Quick Links
What's new
...in the HealthProfessionals section of our website
- 2012-02-01 00:00:00: Case study 72: Management of rhinosinusitis
- 2012-01-16 00:00:00: Apixaban (Eliquis) for preventing venous thromboembolism after knee or hip replacement surgery
- 2012-01-16 00:00:00: NPS RADAR January 2012
More...
Quality Prescribing Indicators in Australian General Practice
Our quality prescribing indicators are designed to support and improve quality prescribing in general practice.
Prescribers who use these quality prescribing indicators can gain insight into their own prescribing and identify areas for quality improvement.
Some indicators promote use of good-quality decision support for prescribing, e.g. access to evidence-based guidelines and up-to-date product information for all drugs.
Other indicators focus on measuring elements of prescribing against best practice guidelines, e.g. percentage of patients with systolic heart failure not currently prescribed an ACE inhibitor or angiotensin II-receptor antagonist.
These indicators have been developed through wide-ranging consultations, testing and review of available evidence and principles of Quality Use of Medicines (QUM).
Date published: 2008-01-01 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.
